trastuzumab deruxtecan
daiichi sankyo,astrazeneca
['solid tumor', 'pantumor', 'trastuzumab deruxtecan', 'rux,(-crux),(-trux)']
#asco23 destiny-pantumor-02: trastuzumab deruxtecan has activity against a range of her2-expressing solid tumors 
Associate Director Community Outreach- DEI- 🫁Thoracic Oncology, University of Miami @SylvesterCancer , 🇵🇷Boricua, Co-founder @KidsHelpingKidsSucceed